ERBB4 (phospho Y1162) polyclonal antibody (Cat # PAB0486) was used to detect Phospho-ERBB4-Y1162 in FG pancreatic carcinoma cell lysate. FG pancreatic carcinoma cells treated with or without EGF (50 ng/ml) for 15 min ERBB4 (phospho Y1162) polyclonal antibody (Cat # PAB0486) was used with 3% BSA. Data and protocol kindly provided by Dr. Weis of Cheresh Lab, UCSD.
Formalin-fixed and paraffin-embedded human hepatocellular carcinoma tissue reacted with ERBB4 (phospho Y1162) polyclonal antibody (Cat # PAB0486) which was peroxidase-conjugated to the secondary antibody followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. HC = hepatocarcinoma.
This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq